Natural killer cells in hepatitis C virus infection

被引:0
作者
Bozzano, Federica [1 ]
Marras, Francesco [2 ]
Biassoni, Roberto [2 ]
De Maria, Andrea [1 ,3 ,4 ]
机构
[1] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy
[2] Ist Giannina Gaslini, I-16148 Genoa, Italy
[3] Univ Genoa, Dept Hlth Sci, Genoa, Italy
[4] Ist Nazl Ric Canc, IRCCS AOU San Martino IST Genova, I-16132 Genoa, Italy
关键词
directly acting antivirals; HCV; HLA; IFN-lambda; IFN-alpha; IL-28B; KIR; natural cytotoxicity receptors; NK cell; protease inhibitors; standard treatment; treatment outcome; BLOOD MONONUCLEAR-CELLS; I-RELATED CHAIN; NK CELLS; DENDRITIC CELLS; INHIBITORY RECEPTORS; SURFACE EXPRESSION; INTERFERON-ALPHA; T-CELLS; HEPATOCELLULAR-CARCINOMA; CYTOTOXICITY RECEPTORS;
D O I
10.1586/ECI.12.71
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Expert Rev. Clin. Immunol. 8(8), 775-788 (2012) Hepatitis C virus (HCV) infection induces the long-term risk of liver cirrhosis or hepatocellular carcinoma and in adults represents the most common cause of liver transplantation. Natural killer (NK) cells participate in innate immune responses with efficient direct antitumor and antiviral defense. Over the years, their complex interaction with downstream adaptive responses and with the regulation of immune responses has been increasingly recognized. Considerable advances have been made particularly in understanding the role of NK cells in the pathophysiology of HCV infection and their possible use as biological markers for clinical purposes. This review summarizes the available data on the role of NK cells in the natural history of HCV infection and their role in the outcome of treatment. The main objective of this review is to summarize recent advancements in the basic understanding of NK cell function highlighting their possible translational use in clinical practice. An integrated practical view on the possible use of currently available predictive immunogenetic and NK cell functional tests is provided, to support clinical management choices for optimal treatment of patients with both standard and new drug regimens.
引用
收藏
页码:775 / 788
页数:14
相关论文
共 119 条
  • [1] Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses
    Ahlenstiel, Golo
    Martin, Maureen P.
    Gao, Xiaojiang
    Carrington, Mary
    Rehermann, Barbara
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (03) : 1017 - 1026
  • [2] Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C
    Ahlenstiel, Golo
    Edlich, Birgit
    Hogdal, Leah J.
    Rotman, Yaron
    Noureddin, Mazen
    Feld, Jordan J.
    Holz, Lauren E.
    Titerence, Rachel H.
    Liang, T. Jake
    Rehermann, Barbara
    [J]. GASTROENTEROLOGY, 2011, 141 (04) : 1231 - U651
  • [3] Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner
    Ahlenstiel, Golo
    Titerence, Rachel H.
    Koh, Christopher
    Edlich, Birgit
    Feld, Jordan J.
    Rotman, Yaron
    Ghany, Marc G.
    Hoofnagle, Jay H.
    Liang, T. Jake
    Heller, Theo
    Rehermann, Barbara
    [J]. GASTROENTEROLOGY, 2010, 138 (01) : 325 - 335
  • [4] What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?
    Alberti, Alfredo
    [J]. LIVER INTERNATIONAL, 2009, 29 : 15 - 18
  • [5] Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus
    Amadei, Barbara
    Urbani, Simona
    Cazaly, Angelica
    Fisicaro, Paola
    Zerbini, Alessandro
    Ahmed, Parvin
    Missale, Gabriele
    Ferrari, Carlo
    Khakoo, Salim I.
    [J]. GASTROENTEROLOGY, 2010, 138 (04) : 1536 - 1545
  • [6] Human NK cell education by inhibitory receptors for MHC class I
    Anfossi, Nicolas
    Andre, Pascale
    Guia, Sophie
    Falk, Christine S.
    Roetynck, Sophie
    Stewart, C. Andrew
    Breso, Violette
    Frassati, Coralie
    Reviron, Denis
    Middleton, Derek
    Romagne, Francois
    Ugolini, Sophie
    Vivier, Eric
    [J]. IMMUNITY, 2006, 25 (02) : 331 - 342
  • [7] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
    Bacon, Bruce R.
    Gordon, Stuart C.
    Lawitz, Eric
    Marcellin, Patrick
    Vierling, John M.
    Zeuzem, Stefan
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Boparai, Navdeep
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Esteban, Rafael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) : 1207 - 1217
  • [8] Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor
    Bartosch, B
    Vitelli, A
    Granier, C
    Goujon, C
    Dubuisson, J
    Pascale, S
    Scarselli, E
    Cortese, R
    Nicosia, A
    Cosset, FL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) : 41624 - 41630
  • [9] Human natural killer cell receptors and co-receptors
    Biassoni, R
    Cantoni, C
    Pende, D
    Sivori, S
    Parolini, S
    Vitale, M
    Bottino, C
    Moretta, A
    [J]. IMMUNOLOGICAL REVIEWS, 2001, 181 : 203 - 214
  • [10] NK Cell Receptors and Their Interactions with MHC
    Biassoni, Roberto
    Ugolotti, Elisabetta
    De Maria, Andrea
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (28) : 3301 - 3310